Clinical Trials for Transfusion Reaction, Hemolytic

Challenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects With or Without Pre-existing Antibodies to INTERCEPT RBCs

NCT ID: NCT07152379

This clinical trial is studying a special type of blood transfusion using red blood cells (RBCs) treated with a technology called INTERCEPT, which helps reduce the risk of infections. The main goal...